RidhiGuptaMD

Oncology • Bronx, NY

Physician

Join to view full profile

Dr. Gupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gupta's full profile

Already have an account?

Office
111 E 210th St
Bronx, NY 10467
Phone+1 718-405-1700

Fax+1 207-621-6102

Education & Training

Medical University of South CarolinaFellowship, Hematology and Medical Oncology, 2017
Westchester Medical CenterResidency, Internal Medicine, 2011 - 2014
Maulana Azad Medical CollegeClass of 2010

Certifications & Licensure

NY State Medical License 2023 - 2025
ME State Medical License 2018 - 2023
CA State Medical License 2017 - 2020
SC State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort.
Mendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, Yogen Saunthararajah, Kira Gritsman
Blood. 2024-11-28
22 citations
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
Robert F. Cornell, Parameswaran Hari, Shijie Tang, Noa Biran, Natalie S. Callander
American Journal of Hematology. 2021-01-01
27 citations
Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review
Yazan Migdady, Asiri Ediriwickrema, Ryan P. Jackson, Wendy Kadi, Ridhi Gupta
Blood Advances. 2020-03-10

Lectures

Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018